The pharmaceutical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a potential development. Unlike shots, this technique offers a less invasive way to deliver GLP-1 drugs. These https://keiranejlh931962.aioblogs.com/93673896/glp-1-patches-a-new-approach-to-blood-sugar-treatment